The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 355:2483-2486 December 7, 2006 Number 23
NextNext

Drug-Eluting Stents in Primary PCI

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Van de Werf, F.
-Related Article
 by Spaulding, C.
-Related Article
 by Laarman, G. J.
-PubMed Citation
To the Editor: In their report on stent use in primary percutaneous coronary intervention (PCI), Spaulding et al. (Sept. 14 issue) suggest that sirolimus-eluting stents are superior to conventional stents in patients with acute myocardial infarction.1 However, some methodologic issues should be addressed. First, despite the randomized design of the study, there were imbalances in most of the procedure-related factors (length and size of the stent and balloon inflation pressure). These imbalances imply the use of different strategies — not disclosed — that might have influenced the results.2 Likewise, the reasons for the poorer early angiographic results (luminal diameter and . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.